The American Association for Respiratory Care (AARC) honored Dräger as a recipient of this year’s Zenith Award during its 64th International Respiratory Conference in Las Vegas. This “people’s choice award” of the respiratory profession honors companies for their quality solutions, customer service and support. AARC members, which include 47,000 respiratory professionals […]
Sleep Disorders
Insomnia Workbook for Teens
Sleep is food for the brain – especially for teens. It’s hard being a teen in today’s fast-paced world. And it’s even harder to reach your goals when you’re feeling tired and run-down. Between early school start times, social media, electronic devices, extracurricular activities, and late-night homework—teens are at the highest […]
Promising Data for First New Narcolepsy Drug in Ten Years, Pending Approval
Platform presentation highlights open-label, long-term safety and tolerability results, durability of effect over time in both EDS and cataplexy in patients with narcolepsy Harmony Biosciences, LLC (Harmony) recently presented new data on pitolisant at the 7th International Symposium on Narcolepsy in Beverly, MA. Pitolisant is an investigational product that has […]
New Study Investigates the Use of Home Monitoring to Screen Children with Down Syndrome for Risk of OSA Prior to Multichannel Sleep Studies
Masimo has announced the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) – who are at high risk of obstructive sleep apnea (OSA) – be recommended to undergo […]
FDA Approves ORKAMBI®, First Medicine to Treat the Underlying Cause of CF for Children Ages 2-5 Years with Most Common Form of the Disease
Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI® (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with cystic fibrosis (CF) who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF […]
Clinical Trial for Treating OSA Using Cannabinoid-based Drug
Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on June 05, 2018, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest […]
Ebb Therapeutics Awarded Medical Design Excellence Award for Insomnia Therapy Device
The Medical Design Excellence Awards (MDEA), the premier awards program for the medtech industry, announced and recognized the 2018 winners across 9 product categories at its annual awards ceremony that took place on June 12, in conjunction with Medical Design and Manufacturing (MD&M) East. Every year, the MDEAs recognize significant achievements […]
Narcolepsy Education Event Coming to NYC Area
NARCOLEPSY EDUCATION DAY PLEASE JOIN US FOR A DAY OF INFORMATION ON NARCOLEPSY AND CONNECTION WITH OTHERS WHOSE LIVES ARE AFFECTED BY NARCOLEPSY When? 9am-3pm SEPTEMBER 22, 2018 Where? AT THE DOUBLETREE HILTON HOTEL TARRYTOWN, NY FOR MORE INFORMATION OR TO REGISTER CONTACT TAMMY SMITH AT tsmith@wakeupnarcolepsy.org WAKE UP NARCOLEPSY IS […]
Nearly 1 Billion People Worldwide Have Sleep Apnea
Researchers analyzed prevalence studies from 16 countries, together with data from the World Health Organization and United Nations World Population Prospects A new data analysis presented by ResMed this week at the ATS 2018 International Conference indicates that the prevalence of sleep apnea impacts more than 936 million people worldwide […]
ResMed’s New QuietAir Diffuser Vent Reduces CPAP Mask Noise by 89 Percent
QuietAir also produces a 70 percent gentler exhaled airflow ResMed today introduced the QuietAir diffuser vent elbow, for its latest CPAP full face masks: AirFit F20 with silicone cushion and AirTouch F20 with memory foam cushion. QuietAir reduces noise by 89 percent and produces a 70 percent gentler exhaled airflow, […]


















